You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Support for your adult patients who are receiving Nucala treatment

Go to Top Close

Providing you with practical tips and advice for your adult patients receiving Nucala.

Nucala is a long-term treatment that requires planning

It is important to remind your patients that Nucala is intended for long-term treatment. The need for continued therapy should be considered at least on an annual basis as determined by Physician assessment of the patient’s disease severity and level of control of exacerbations. Nucala is given as a single injection, once every 4 weeks by a healthcare professional, and so patients may need to plan for about 13 injections every year.1

It may be useful to spend some time with your patient to help plan how they will fit their injections into their schedule and identify possible problems that they may need to overcome, such as arranging:

  • Time off work, and how to talk to their employer
  • Child care if they have young children
  • Transport to the clinic or researching local public transport links

Around one fifth of people have a fear of needles2

If your patient has needle phobia, it may result in avoidance of medical care.2 Therefore it might help to ask your patient upfront about how comfortable they feel receiving regular injections.

Asthma triggers vary widely from patient to patient3

There are several known triggers for asthma, and these vary widely from patient to patient.3 While most people with severe asthma will be aware of their triggers, it may still be useful to talk to your patient about possible triggers and steps they can take to minimise them.

Common asthma triggers include:3

  • Dust
  • Viral infections (e.g. colds)
  • Coughing
  • Smoking or smoke
  • Exercise
  • Stress
  • Strong smells
  • Changes in weather
  • Mould
  • Animals

Dedicated supporters can often help patients

As a healthcare provider, the support you provide your patients is invaluable. However, it is not possible for you to be there for your patient all the time.
Talk to your patient about who else they might be able to turn to for support. For some patients, it may be useful for them to nominate a dedicated supporter. This can be a family member, a friend or even a work colleague who they can turn to and share their concerns with.

References:

  1. Nucala SmPC, 2019. Available at www.medicines.ie. Accessed January 2019.
  2. Wright S et al. Aust Fam Physician 2009; 38:172–176.
  3. Price D et al. J Asthma 2014; 51(2): 127-135.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Adverse events should be reported to the Health Products Regulatory Authority (HPRA) using an Adverse Reaction Report Form obtained either from the HPRA or electronically via the website at www.hpra.ie. Adverse reactions can also be reported to the HPRA by calling: (01) 6764971. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Copyright © 2019 GlaxoSmithKline Group of Companies. All rights reserved.
Nucala is a registered trademark of the GlaxoSmithKline Group of Companies.